This brand name is authorized in Cyprus
The drug PIZOGRAN contains one active pharmaceutical ingredient (API):
|
1
Pizotifen
UNII 0BY8440V3N - PIZOTYLINE
|
|
Pizotifen is a tricyclic (Benzocycloheptathiophene) compound possessing structural similarities to cyproheptadine and the tricyclic antidepressant drugs. Pharmacodynamic studies demonstrate pizotifen to have powerful antiserotonin and antitryptaminic properties, marked antihistaminic effects and some antagonistic activity against kinins. The prophylactic effect of pizotifen in migraine is associated with its ability to modify the humoral mechanisms of headache. |
Below package inserts are available for further reading:
| Title | Information Source | Document Type | |
|---|---|---|---|
| PIZOGRAN Film-coated tablet | Υπουργείο Υγείας (CY) | MPI, EU: SmPC |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| N02CX01 | Pizotifen | N Nervous system → N02 Analgesics → N02C Antimigraine preparations → N02CX Other antimigraine preparations |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
